Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |